CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial
Jia Liu(The University of Sydney), Lin Shen(Peking University), Jinbo Yue(Shandong Tumor Hospital), Aiping Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Andrea Tazbirkova(Canossa Private Hospital), Zimin Liu(Qingdao University), Hui Zhou, Yuping Sun(Shandong University), Juan Du(Cleveland Clinic Lerner College of Medicine), Xiuying Xiao(Fudan University Shanghai Cancer Center), Yingmei Guo, Jian Ruan(TCM-Intigrated Cancer Center of Southern Medical University), Yang Luo(Southwest Medical University), Weiming Yu(Zhejiang Normal University), Yanru Qin(First Affiliated Hospital of Zhengzhou University), Yueyin Pan(Anhui Provincial Hospital), Chuangxin Lu(Henan Provincial People's Hospital), Meili Sun(Jinan Central Hospital), Ping Chen(Ningxia Medical University), Zhi‐Hua Li(Sun Yat-sen University), Xianjun Yu(Hubei University of Medicine), Jianwei Yang(Fujian Provincial Cancer Hospital), Ting Deng(Tianjin Medical University Cancer Institute and Hospital), Xin Zhao(Capital Medical University), Xinjun Liang(Hubei Cancer Hospital), Jian Zhang(Vanderbilt University), Jie Li(Karamay Central Hospital of Xinjiang), Suyi Li(Anhui Provincial Hospital), Xianglin Yuan(Tongji Hospital), Enxiao Li(First Affiliated Hospital of Xi'an Jiaotong University), Lili Sheng(First Affiliated Hospital of Wannan Medical College), Zhenyang Liu(Qingdao University), Jieer Ying(Zhejiang Cancer Hospital), Jifang Gong(Peking University), Rongfeng Song(Jiangxi Provincial Cancer Hospital), Michelle Frances Morris(Sunshine Coast University Hospital), Yiping Mou(Zhejiang Provincial People's Hospital), Xiujuan Qu(First Hospital of China Medical University)
Cited by 29
Related Papers
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657